104 related articles for article (PubMed ID: 10424019)
1. [The Berlipril and Retalzem treatment of hypertension patients: the dynamics of the clinico-hemodynamic indices and of the vasodilating humoral factors].
Koval' SN; Starchenko TG; Gorb IuG; Pen'kova MIu; Khasanova KhD
Lik Sprava; 1999; (1):113-7. PubMed ID: 10424019
[TBL] [Abstract][Full Text] [Related]
2. Long-term effectiveness of enalapril plus extended-release diltiazem in essential hypertension.
Applegate W; Cohen JD; Wolfson P; Davis A; Green S
Pharmacotherapy; 1997; 17(1):107-12. PubMed ID: 9017770
[TBL] [Abstract][Full Text] [Related]
3. Felodipine as monotherapy and associated with enalapril for essential hypertension.
Navarro JF; García-Pérez J; Rodríguez-Pérez JC
Am J Cardiol; 1997 Sep; 80(5):683-4. PubMed ID: 9295013
[No Abstract] [Full Text] [Related]
4. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
[TBL] [Abstract][Full Text] [Related]
5. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.
Karotsis AK; Symeonidis A; Mastorantonakis SE; Stergiou GS;
Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064
[TBL] [Abstract][Full Text] [Related]
6. [Pathogenetic approaches to the differentiated drug therapy of hypertension].
Malaia LT; Vasyl'iev IuM; Babadzhan VD; Koval' SN
Lik Sprava; 1997; (3):47-51. PubMed ID: 9377352
[No Abstract] [Full Text] [Related]
7. [Changes in the central hemodynamics during the treatment of hypertension with Renitec and its combination with hydrochlorothiazide].
Malaia LT; Lapshina LA; Bil'chenko AV; Shkapo VL
Lik Sprava; 1996; (7-9):57-60. PubMed ID: 9072267
[TBL] [Abstract][Full Text] [Related]
8. Curative effect of amlodipine combined with enalapril in curing hypertension of the aged.
Li X; Zhang L; Jian L; Li L; Niu S
Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):693-6. PubMed ID: 25796146
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of the fixed lercanidipine-enalapril combination in the treatment of patients with essential hypertension.
Rump LC
Arzneimittelforschung; 2010; 60(3):124-30. PubMed ID: 20422943
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
11. [Comparative evaluation of the antihypertensive efficacy of amlodipine versus enalapril].
Alicajić F
Med Arh; 2009; 63(1):42-3. PubMed ID: 19419127
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Hypertensive Patients With Diabetes and Microalbuminuria With Combination Indapamide SR/Amlodipine: Retrospective Analysis of NESTOR.
Hanon O; Boully C; Caillard L; Labourée F; Cochiello S; Chaussade E
Am J Hypertens; 2015 Aug; 28(8):1064-71. PubMed ID: 25628416
[TBL] [Abstract][Full Text] [Related]
13. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
14. Is hypertension a disease, and is it time to shift the paradigm?
Lewis WR
Prev Cardiol; 2006; 9(1):6-7. PubMed ID: 16407696
[No Abstract] [Full Text] [Related]
15. Calcium antagonist stopped in ABCD study. Appropriate Blood Pressure Control in Diabetes.
Husten L
Lancet; 1998 Mar; 351(9104):731. PubMed ID: 9504527
[No Abstract] [Full Text] [Related]
16. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE
Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
[TBL] [Abstract][Full Text] [Related]
17. [Fundamental research--a basis for the synthesis of new hypotensive drugs].
Almazov VA; Shliakhto EV
Kardiologiia; 1991 Dec; 31(12):24-8. PubMed ID: 1687751
[TBL] [Abstract][Full Text] [Related]
18. [Study of the efficacity and tolerance of diltiazem LP 300 mg in 2000 hypertensive patients (alone or combined with an angiotensin converting enzyme inhibitor].
Amar J; Joire JE; Salvador M
Ann Cardiol Angeiol (Paris); 1999 Jan; 48(1):69-75. PubMed ID: 12555361
[No Abstract] [Full Text] [Related]
19. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
[TBL] [Abstract][Full Text] [Related]
20. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
